Oncology

sponsor

Topics in Oncology

Alternative Therapies

Anemia/Polycythemia

Basic Science/Genetics

Coagulation/Bleeding Dz

Colorectal Cancer/Polyps

Dermatologic Oncology

Diagnostics/Radiology

Economics of Medicine

Endocrine Oncology

Gynecologic Oncology

Hepatobiliary/Pancreas

Leukemia/Lymphoma

Lung/Thoracic Oncology

Myeloproliferative Dz

Neurologic Oncology

Pain Management/
Palliative Care

Pediatric Heme/Oncology

Pharmacology/Therapy

Soft Tissue/Sarcoma

Transfusion Medicine

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Top Ten Searches

brca1

prostate-specific antigen

sclc

fobt

egd

bmi

dysplasia

hematologic

ovarian

hcc

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial
Transfusion, 09/08/09

Van Wyck DB et al. – In patients with iron deficiency anemia due to heavy uterine bleeding, rapid IV administration of large doses of a new iron agent, ferric carboxymaltose, is more effective than oral iron therapy in correcting anemia, replenishing iron stores, and improving quality of life.

<< Previous
Oral Assessment Guide – test of reliability and validity for...

Next >>
Inflammatory Biomarkers and Fatigue during Radiation Therapy for...

Related Articles

Safety and tolerability of intravenous ferric carboxymaltose in patients with iron deficiency anemia
Hemodialysis International, 11/05/09 Relevance Score: 66%

Rationale and design of Ferinject Assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia
European Journal of Heart Failure, 11/02/09 Relevance Score: 64%

Use of agents stimulating erythropoiesis in digestive diseases
World Journal of Gastroenterology, 10/12/09 Relevance Score: 40%

Today in Anemia/Polycythemia...keeping you current

Asymptomatic brain magnetic resonance imaging abnormalities in splenectomized adults with thalassemia intermedia
Journal of Thrombosis and Haemostasis, 12/19/09

Hematogones are markedly reduced in pediatric acquired aplastic anemia: multiparametric flow cytometric analysis
Leukemia and Lymphoma, 12/17/09

Red Blood Cell Distribution Width and Risk of Cardiovascular Events and Mortality in a Community Cohort in Taiwan
American Journal of Epidemiology, 12/17/09

See all of Anemia/Polycythemia

Today in Pharmacology/Therapy...keeping you current

Nilotinib As Front-Line Treatment for Patients With Chronic Myeloid Leukemia in Early Chronic Phase
Journal of Clinical Oncology, 12/20/09

Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance
Journal of Clinical Oncology, 12/20/09

Safety and Efficacy of Romiplostim in Patients With Lower-Risk Myelodysplastic Syndrome and Thrombocytopenia
Journal of Clinical Oncology, 12/20/09

See all of Pharmacology/Therapy

Sponsor

Article Search

Sponsor

Sponsor

Send this Summary to a Colleague